News | February 19, 2022
UAE to recognise Indian pharma products within three months
The agreement also had a permanent safeguard mechanism which can be resorted to in a situation of sudden surge in imports.
The agreement also had a permanent safeguard mechanism which can be resorted to in a situation of sudden surge in imports.
With this approval, Brukinsa is now approved in 44 markets as BeiGene continues to advance its global registration, including the EU, US, and Great Britain
Moderna's vaccine has already received regulatory approval for adults and adolescents in Australia
AstraZeneca will hold the registration and manufacture Pulmicort Respules, while Glenmark will commercialize the product in Columbia
Medtech plays a vital role in the healthcare system and players in this field believe that the budget should address some of their concerns if India has to become a formidable player
The company develops sustainable botanical materials for agricultural and pharmaceutical applications
This is the company’s first partnership arrangement in China
First Positive Study for KEYTRUDA in Adjuvant Stage IB-IIIA NSCLC
ASC10 is an oral direct-acting antiviral drug candidate targeting RNA dependent RNA polymerase (RdRp) to treat SARS-CoV-2 infection
The NMPA approval is based on the positive data of GEMSTONE-302 study, a multi-center, randomized, double-blind, phase III study that evaluated the efficacy and safety of Cejemly or placebo in combination with chemotherapy in first-line stage IV NSCLC patients
Subscribe To Our Newsletter & Stay Updated
